TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
CellSource Co., Ltd. ( (JP:4880) ) has shared an update.
CellSource Co., Ltd. has announced the issuance of stock options to its employees, aimed at boosting corporate value and improving performance over the medium to long term. The issuance involves 1,582 stock acquisition rights, which, if fully exercised, will result in a maximum dilution of 0.8% of the total issued shares. The company believes this move will enhance shareholder value and considers the dilution impact to be within a reasonable range.
The most recent analyst rating on (JP:4880) stock is a Buy with a Yen1600.00 price target. To see the full list of analyst forecasts on CellSource Co., Ltd. stock, see the JP:4880 Stock Forecast page.
More about CellSource Co., Ltd.
CellSource Co., Ltd. operates in the biotechnology industry, focusing on enhancing corporate value through innovative business activities. The company is listed on the Tokyo Stock Exchange, Prime Market, under the securities code 4880.
Average Trading Volume: 69,300
Technical Sentiment Signal: Sell
Current Market Cap: Yen13.83B
For an in-depth examination of 4880 stock, go to TipRanks’ Stock Analysis page.